21 related articles for article (PubMed ID: 15730616)
1. Inverse expression of survivin and reprimo correlates with poor patient prognosis in gastric cancer.
Cerda-Opazo P; Valenzuela-Valderrama M; Wichmann I; Rodríguez A; Contreras-Reyes D; Fernández EA; Carrasco-Aviño G; Corvalán AH; Quest AFG
Oncotarget; 2018 Feb; 9(16):12853-12867. PubMed ID: 29560115
[TBL] [Abstract][Full Text] [Related]
2. Molecular docking and analysis of survivin delta-ex3 isoform protein.
Ezziane Z
Open Med Chem J; 2008 Mar; 2():16-20. PubMed ID: 19662140
[TBL] [Abstract][Full Text] [Related]
3. Chemoresponse to docetaxel correlates with expression of the survivin splicing variants in patients with gastric cancer.
Meng H; Tanigawa N; Hao CY; Dai DJ; Lu CD; Ji JF
Hepatogastroenterology; 2007; 54(79):1934-40. PubMed ID: 18251132
[TBL] [Abstract][Full Text] [Related]
4. [Exploration on the increased sensitivity to docetaxel and reversing mechanism of drug resistance of antisense survivin RNA in gastric cancer cell line SGC7901 cells].
Ma R; Chen XH; Zhang QF; Zhu L; Tang LP; Wang J; Cheng HY; Lei LN
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):89-92. PubMed ID: 17645838
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of βIII-tubulin and survivin associated with drug resistance to docetaxel-based chemotherapy in advanced gastric cancer.
Zheng WE; Chen H; Yuan SF; Wu LL; Zhang W; Sun HY; Chen WJ
J BUON; 2012; 17(2):284-90. PubMed ID: 22740207
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic significance of survivin splicing variants in expression gastric cancer].
Meng H; Dai DJ; Lu CD
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):234-6. PubMed ID: 16167236
[TBL] [Abstract][Full Text] [Related]
8. [Recent advance in gastric cancer chemotherapy].
Kubota T
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2043-7. PubMed ID: 11103235
[TBL] [Abstract][Full Text] [Related]
9. Survivin: potential role in diagnosis, prognosis and targeted therapy of gastric cancer.
Wang TT; Qian XP; Liu BR
World J Gastroenterol; 2007 May; 13(20):2784-90. PubMed ID: 17569112
[TBL] [Abstract][Full Text] [Related]
10. [Elevated expression level of wild-type survivin in gastric cancer promotes in vitro docetaxel-resistance].
Meng H; Lu CD; Dai DJ; Sun YL; Tanigawa N
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2060-3. PubMed ID: 15730616
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
